Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kura Oncology (KURA) Other Operating Expenses (2026)

Kura Oncology has reported Other Operating Expenses over the past 1 years, most recently at $262000.0 for Q1 2026.

  • Quarterly Other Operating Expenses changed N/A to $262000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $262000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $57000.0 for FY2025, N/A changed from the prior year.
  • Other Operating Expenses was $262000.0 for Q1 2026 at Kura Oncology.
  • Over five years, Other Operating Expenses peaked at $262000.0 in Q1 2026 and troughed at $262000.0 in Q1 2026.